Molecular imaging of pulmonary cancer and inflammation

Proceedings of the American Thoracic Society

Volumn 6, Issue 5, 2009, Pages 464-468

  Divgi, Chaitanya R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Infection; PET; Radiolabeled ligands; SPECT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GALLIUM CITRATE GA 67; INDIUM 111; MACROSALB TC 99M; TECHNETIUM 99M; THIOSEMICARBAZONE DERIVATIVE; THYMIDINE C 11; THYMIDINE F 18; TRACER; UNCLASSIFIED DRUG;

BONE METASTASIS; CANCER STAGING; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; GLYCOLYSIS; HUMAN; LUNG CANCER; LUNG NODULE; LUNG PARENCHYMA; LUNG TUBERCULOSIS; LYMPH NODE METASTASIS; METASTASIS; PHENOTYPE; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MOLECULAR IMAGING; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 69249219282     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200902-005AW     Document Type: Conference Paper

References (18)

1. 18FDG PET scanning in oncology. Br J Cancer 2008;98:1597-1601.
2. Bar-Shalom R, Kagna O, Israel O, Guralnik L. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D- glucose avidity on positron emission tomography/computed tomography. Cancer 2008;113:3213-3221.
3. Schöder H, Moskowitz C. PET imaging for response assessment in lymphoma: potential and limitations. Radiol Clin North Am 2008;46: 225-241. (Pubitemid 351932048)
4. Bading JR, Shields AF. Imaging of cell proliferation: status and prospects. J Nucl Med 2008;49:64S-80S.
5. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol 2008;3:177-186. (Pubitemid 351323195)
6. Mac Manus MP, Hicks RJ. Impact of PET on radiation therapy planning in lung cancer. Radiol Clin North Am 2007;45:627-638.
7. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008;35:1537-1543.
8. Lee FT, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med 2007;37:451-461. (Pubitemid 47498258)
9. Chen DL, Dehdashti F. Advances in positron emission tomographic imaging of lung cancer. Proc Am Thorac Soc 2005;2:541-544. (Pubitemid 43128027)
10. 18F-FDG. J Nucl Med 2008;49:22-29.
11. 3 expression. Nucl Med Biol 2006;33:945-952.
12. Zhang G, Dilling TJ, Stevens CW, Forster KM. Functional lung imaging in thoracic cancer radiotherapy. Cancer Control 2008;15:112-119.
13. Kroe DM, Kirsch CM, Jensen WA. Diagnostic strategies for Pneumocystis carinii pneumonia. Semin Respir Infect 1997;12:70-78. (Pubitemid 27259953)
14. Divgi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, Merchant B, Schweighart S, Unger M, Larson SM, et al. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991;83:97-104.
15. Krug LM, Milton DT, Jungbluth AA, Chen LC, Quaia E, Pandit-Taskar N, Nagel A, Jones J, Kris MG, Finn R, et al. Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels. J Thorac Oncol 2007;2:947-952. (Pubitemid 47511599)
16. Mac Manus M, Hicks RJ. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review. Int J Radiat Oncol Biol Phys 2008; 72:1298-1306.
17. Macapinlac HA. Clinical applications of positron emission tomography/computed tomography treatment planning. Semin Nucl Med 2008;38: 137-140. (Pubitemid 351163198)
18. 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). J Exp Clin Cancer Res 2008;27:52.